Perstorp to Buy Solvay’s Caprolactone Business

Perstorp says it has agreed to buy Solvay’s caprolactone business for €200 million ($284.7 million). The business reported sales of €60 million last year, and employs 65, Solvay says. The deal includes a manufacturing plant at Warrington, U.K. Solvay says the caprolactone business “does not result in synergies” with its other chemicals and plastics operations. Perstorp says it plans to double the capacity for caprolactone as well as increase capacities for downstream derivatives to meet an increase in demand from all the major applications for the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers